Skip to main content
Fig. 4 | The Journal of Headache and Pain

Fig. 4

From: Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study

Fig. 4

Health economic questionnaire data from German patients in the SAF enrolled before 08 April 2014. Percentage of patients who had been incapacitated for work () or reported a disability (■) in the last 6 months prior to baseline or since the last visit, and the percentage of patients that had been absent from school or work (▲) or stated that performance at school or work had been impaired when having a headache at school/work (♦) in the last 4 weeks prior to baseline or since the last visit. Percentages are related to the number of patients at the respective visit. Non-overlapping 95% confidence intervals at each time point vs. baseline are denoted by * for absenteeism, # for work incapacity, and ‡ for impaired performance; non-overlapping 95% Cis show statistical significance

Back to article page